Skip to main content
HeartCited

High Blood Pressure (Hypertension)
High Blood Pressure (Hypertension)

Prevalensi: 47% of US adults (116 million); ~1.28 billion adults worldwide

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'condition\u003Dhigh\u002Dblood\u002Dpressure'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Evidence-Ranked Ingredients

About

{# Filter order is load-bearing: escape (untrusted text) -> linebreaks (paragraphs) -> paper anchors (internal /papers/ links) -> glossary (never links inside an existing ). #}

Hypertension is defined by a pressure that stays elevated at rest, not by any sensation, which is why roughly 47 percent of US adults meet the criteria while most of them feel entirely well. The worldwide figure approaches 1.28 billion adults. Nineteen ingredients carry an evidence grade against blood pressure in this collection, drawn from 246 studies and about 44,300 participants, and the distribution is unusually top-heavy for a supplement literature: two Grade A, ten Grade B, seven Grade C, and nothing below.

The two Grade A entries share a mechanism. Beetroot extract, graded on 16 studies and 800 participants, supplies inorganic nitrate that is reduced by oral bacteria to nitrite and then to nitric oxide, the endogenous vasodilator that sets resting arterial tone. Garlic, graded on 12 studies and 550 participants, acts through a partly overlapping route involving allicin-derived sulfur compounds. Both have been examined mainly in people whose pressure was already raised, where the measurable room for change is larger than in normotensive volunteers.

Grade B is where the mineral evidence sits. Magnesium carries the widest study base of any ingredient here, 34 studies across 2,028 participants, followed by potassium at 22 studies and 1,600 participants. Their actions are physiologically related: both influence vascular smooth-muscle tone and renal sodium handling, and both are commonly under-consumed in the same processed-food diets that supply the excess sodium listed first among the risk factors. The other Grade B entries are polyphenols and lipids rather than minerals, with quercetin at 17 studies, grape seed extract at 16, coenzyme Q10 at 12, flaxseed oil at 11, resveratrol at 10, taurine at 7, lycopene at 6, and olive leaf extract at 5.

Direction of effect is not uniform. Seventeen of the nineteen ingredients are recorded as positive, but vitamin D and calcium are both Grade C with a mixed direction, and vitamin D alone accounts for 30,000 of the 44,288 participants in the entire set. The imbalance is instructive: the largest trials in this collection are the ones that failed to show a consistent effect. One such trial, which randomised vitamin D and marine omega-3 fatty acids in adults without established cardiovascular disease, was designed around exactly that problem of detecting a small effect in a well-nourished population [1].

Cocoa flavanols occupy a comparable position at Grade C on 20 studies and 1,000 participants, with reasonably consistent short-term vascular readouts and less consistent evidence for sustained pressure change. L-citrulline, berberine, nattokinase and hawthorn are each graded C on four to eight studies, a base too narrow to separate a genuine effect from small-trial noise.

Botanical preparations warrant particular caution in this condition, because the people taking them overlap heavily with the people taking antihypertensive drugs. Pharmacy reviews of herbal products have catalogued the interactions and safety concerns that arise from that overlap [2]. Blood pressure also responds to factors no ingredient addresses: sodium intake, body weight, physical inactivity, alcohol, and untreated sleep apnea all appear among the established risk factors, and each rests on a larger evidence base than any supplement on this page.

Common Symptoms

Often asymptomatic ('silent killer') Severe: headache, shortness of breath, nosebleeds Chest pain Visual changes Dizziness

Risk Factors

  • Excess sodium intake
  • Obesity
  • Physical inactivity
  • Excess alcohol
  • Family history
  • Age
  • Diabetes
  • Sleep apnea

Frequently Asked Questions

What supplements may help with High Blood Pressure (Hypertension)?
Based on peer-reviewed research, supplements with the strongest evidence for High Blood Pressure (Hypertension) include Beetroot Extract, Garlic, Magnesium, Potassium. These have earned Grade A or B ratings from our analysis of clinical studies. Always consult your healthcare provider before starting any supplement.
How is the evidence for High Blood Pressure (Hypertension) supplements graded?
We grade supplements on an A-F scale based on clinical study quality, consistency of results, sample sizes, and study design. Grade A indicates strong evidence from multiple clinical trials, while Grade D indicates preliminary evidence requiring further research.
How many studies on High Blood Pressure (Hypertension) supplements have been reviewed?
Our evidence grades for High Blood Pressure (Hypertension) are based on a total of 246 peer-reviewed studies across 19 ingredients. Studies are sourced from PubMed and include randomized controlled trials, meta-analyses, and other clinical research.
What are common symptoms of High Blood Pressure (Hypertension)?
Common symptoms associated with High Blood Pressure (Hypertension) include Often asymptomatic ('silent killer'), Severe: headache, shortness of breath, nosebleeds, Chest pain, Visual changes, Dizziness. If you are experiencing these symptoms, consult a healthcare professional for proper diagnosis and treatment options.

References

  1. 1. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemporary clinical trials, 2012 PMID 21986389
  2. 2. Unsafe and potentially safe herbal therapies. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1999 PMID 10030529

Kondisi yang berbagi bahan yang telah diteliti

Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.